
Quarterly ResultAug 5, 2026, 04:16 PM
agilon health Q2 Revenue $1.49B, Net Income $18M; Raises FY26 Guidance
AI Summary
agilon health reported strong second quarter 2026 financial results, with total revenue increasing 7% to $1.49 billion and net income reaching $18 million, a substantial turnaround from a loss in the prior year. Adjusted EBITDA also turned positive at $70 million. Following these results, the company raised its full-year 2026 guidance for total revenues, medical margin, and Adjusted EBITDA, citing improved burden of illness execution and favorable medical cost trends.
Key Highlights
- Q2 2026 Total Revenue increased 7% to $1.49 billion compared to $1.39 billion in Q2 2025.
- Q2 2026 Net Income was $18 million, a significant improvement from a net loss of $104 million in Q2 2025.
- Q2 2026 Adjusted EBITDA was $70 million, up from negative $83 million in Q2 2025.
- Q2 2026 Medical Margin was $197 million, compared to negative $53 million in Q2 2025.
- Full-Year 2026 Total Revenues guidance raised to $5.775 billion - $5.860 billion.
- Full-Year 2026 Medical Margin guidance raised to $465 million - $505 million.
- Full-Year 2026 Adjusted EBITDA guidance raised to $75 million - $95 million.
- Total members on the agilon platform decreased 10% to 549,000 as of June 30, 2026.
Price Impact
More from AGL